Log in to save to my catalogue

Stability and Oligomerization of Mutated SMN Protein Determine Clinical Severity of Spinal Muscular...

Stability and Oligomerization of Mutated SMN Protein Determine Clinical Severity of Spinal Muscular...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8872419

Stability and Oligomerization of Mutated SMN Protein Determine Clinical Severity of Spinal Muscular Atrophy

About this item

Full title

Stability and Oligomerization of Mutated SMN Protein Determine Clinical Severity of Spinal Muscular Atrophy

Publisher

Switzerland: MDPI AG

Journal title

Genes, 2022-01, Vol.13 (2), p.205

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Spinal muscular atrophy (SMA) is a common autosomal recessive neuromuscular disease characterized by defects of lower motor neurons. Approximately 95% of SMA patients are homozygous for
(
) gene deletion, while ~5% carry an intragenic
mutation. Here, we investigated the stability and oligomerization ability of mutated SMN1 proteins. Plasmi...

Alternative Titles

Full title

Stability and Oligomerization of Mutated SMN Protein Determine Clinical Severity of Spinal Muscular Atrophy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8872419

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8872419

Other Identifiers

ISSN

2073-4425

E-ISSN

2073-4425

DOI

10.3390/genes13020205

How to access this item